Avalon Investment & Advisory lessened its position in CME Group Inc (NASDAQ:CME) by 8.5% in the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 69,538 shares of the financial services provider’s stock after selling 6,464 shares during the quarter. Avalon Investment & Advisory’s holdings in CME Group were worth $11,303,000 as of its most recent filing with the Securities & Exchange Commission.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in CME. BlackRock Inc. lifted its stake in CME Group by 4.6% in the 1st quarter. BlackRock Inc. now owns 26,645,530 shares of the financial services provider’s stock worth $4,607,281,000 after purchasing an additional 1,179,970 shares in the last quarter. Edgewood Management LLC lifted its position in CME Group by 3.2% in the first quarter. Edgewood Management LLC now owns 7,849,764 shares of the financial services provider’s stock valued at $1,357,303,000 after acquiring an additional 246,376 shares during the last quarter. Parnassus Investments CA lifted its position in CME Group by 9.7% in the first quarter. Parnassus Investments CA now owns 3,903,136 shares of the financial services provider’s stock valued at $674,891,000 after acquiring an additional 346,212 shares during the last quarter. Bank of New York Mellon Corp raised its holdings in shares of CME Group by 1.7% in the first quarter. Bank of New York Mellon Corp now owns 3,439,199 shares of the financial services provider’s stock valued at $594,670,000 after buying an additional 58,441 shares during the last quarter. Finally, Fiera Capital Corp raised its holdings in shares of CME Group by 4.4% in the first quarter. Fiera Capital Corp now owns 3,437,750 shares of the financial services provider’s stock valued at $594,424,000 after buying an additional 145,986 shares during the last quarter. Institutional investors own 84.83% of the company’s stock.
In other news, Director William R. Shepard bought 771 shares of CME Group stock in a transaction that occurred on Tuesday, June 2nd. The stock was bought at an average price of $178.10 per share, for a total transaction of $137,315.10. Following the purchase, the director now directly owns 771 shares of the company’s stock, valued at approximately $137,315.10. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Timothy S. Bitsberger sold 600 shares of the stock in a transaction dated Monday, June 8th. The stock was sold at an average price of $191.32, for a total value of $114,792.00. Following the sale, the director now directly owns 9,927 shares in the company, valued at $1,899,233.64. The disclosure for this sale can be found here. Insiders have sold a total of 9,500 shares of company stock worth $1,593,810 in the last ninety days. Insiders own 1.20% of the company’s stock.
Shares of CME stock traded up $0.98 during mid-day trading on Thursday, hitting $173.18. The company’s stock had a trading volume of 34,239 shares, compared to its average volume of 1,700,254. CME Group Inc has a 52-week low of $131.80 and a 52-week high of $225.36. The business has a 50-day moving average price of $166.66 and a 200 day moving average price of $182.50. The company has a debt-to-equity ratio of 0.13, a quick ratio of 1.02 and a current ratio of 1.02. The stock has a market cap of $62.18 billion, a price-to-earnings ratio of 26.22, a PEG ratio of 5.71 and a beta of 0.30.
CME Group (NASDAQ:CME) last posted its quarterly earnings results on Wednesday, July 29th. The financial services provider reported $1.63 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.62 by $0.01. CME Group had a return on equity of 9.93% and a net margin of 46.39%. The firm had revenue of $1.18 billion during the quarter, compared to analysts’ expectations of $1.20 billion. During the same quarter in the previous year, the business earned $1.76 earnings per share. The company’s revenue was down 7.1% on a year-over-year basis. Equities research analysts predict that CME Group Inc will post 7.04 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Thursday, September 10th will be given a dividend of $0.85 per share. The ex-dividend date is Wednesday, September 9th. This represents a $3.40 annualized dividend and a yield of 1.96%. CME Group’s dividend payout ratio (DPR) is presently 50.00%.
A number of brokerages have recently issued reports on CME. Rosenblatt Securities dropped their price target on shares of CME Group from $140.00 to $130.00 and set a “sell” rating on the stock in a research note on Thursday, July 30th. BidaskClub lowered shares of CME Group from a “sell” rating to a “strong sell” rating in a research note on Tuesday, July 14th. Deutsche Bank dropped their price target on shares of CME Group from $196.00 to $178.00 and set a “buy” rating on the stock in a research note on Thursday, July 30th. Bank of America dropped their price target on shares of CME Group from $194.00 to $180.00 and set a “neutral” rating on the stock in a research note on Friday, July 10th. Finally, UBS Group boosted their price target on shares of CME Group from $222.00 to $225.00 and gave the stock a “buy” rating in a research note on Thursday, April 30th. Four analysts have rated the stock with a sell rating, eight have issued a hold rating and seven have issued a buy rating to the company. The company has a consensus rating of “Hold” and a consensus target price of $187.88.
CME Group Profile
CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.
Featured Article: Stochastic Momentum Index (SMI)
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.